Literature DB >> 19870921

RADIOACTIVE IRON AND ITS EXCRETION IN URINE, BILE, AND FECES.

P F Hahn1, W F Bale, R A Hettig, M D Kamen, G H Whipple.   

Abstract

Radioactive iron as ferrous gluconate given by vein enables us to study iron excretion in urine, bile, and feces. There is an initial extra output in urine and feces during a few days (3 to 15 days) following the iron injection and this may total 2 to 8 per cent of the injected iron. Following this initial reaction the urinary excretion of radio-iron drops to traces or even to zero. The feces always contain measurable amounts of radio-iron-in five dogs receiving 100 to 250 mg. of radio-iron the fecal excretion per day settled down to 0.05 to 0.4 mg. per day. Blood destruction (acetyl-phenylhydrazine) causes a definite increase in radio-iron eliminated in the feces (0.1 to 1.0 mg. per day). Probably most of this excess iron comes through the biliary tract (bile fistula). The bile under usual conditions contributes very little iron to the intestine (0.01 mg. radio-iron per day or less). The body controls its iron stores by absorption or lack of it rather than by its capacity to eliminate it. The evidence is overwhelming that the dog excretes iron with difficulty and in small amounts (even in the plethoric state) by means of the biliary and gastro-intestinal tracts.

Entities:  

Year:  1939        PMID: 19870921      PMCID: PMC2133804          DOI: 10.1084/jem.70.5.443

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  The absorption and excretion of iron following oral and intravenous administration.

Authors:  R A McCance; E M Widdowson
Journal:  J Physiol       Date:  1938-10-14       Impact factor: 5.182

2.  A METHOD FOR THE PERMANENT STERILE DRAINAGE OF INTRAABDOMINAL DUCTS, AS APPLIED TO THE COMMON DUCT.

Authors:  P Rous; P D McMaster
Journal:  J Exp Med       Date:  1923-01-01       Impact factor: 14.307

3.  RADIOACTIVE IRON AND ITS METABOLISM IN ANEMIA : ITS ABSORPTION, TRANSPORTATION, AND UTILIZATION.

Authors:  P F Hahn; W F Bale; E O Lawrence; G H Whipple
Journal:  J Exp Med       Date:  1939-04-30       Impact factor: 14.307

  3 in total
  13 in total

1.  [Urinary iron in normal late pregnancy and in late toxicoses].

Authors:  K ROTHE; K BILEK; K PISKAZECK
Journal:  Arch Gynakol       Date:  1960

2.  [Colloidal ferrosaccharate therapy].

Authors:  E GISINGER; H VETTER
Journal:  Blut       Date:  1956-10

3.  [Experimental and clinical studies on pregnancy sideropenia with a radioactive iron complex].

Authors:  H A KUNKEL; H MAASS; H J SCHMERMUND; H GOLDECK
Journal:  Klin Wochenschr       Date:  1954-09-15

4.  Sequestration and scavenging of iron in infection.

Authors:  Nermi L Parrow; Robert E Fleming; Michael F Minnick
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

5.  Changes of iron metabolism in renal diseases.

Authors:  A M Gasparyan; M M Scherba; W N Tkatchuck; B I Gurin; D B Zykin
Journal:  Int Urol Nephrol       Date:  1971       Impact factor: 2.370

6.  Endogenous iron excretion. A quantitative means to control iron metabolism?

Authors:  M Kreuzer; M Kirchgessner
Journal:  Biol Trace Elem Res       Date:  1991-05       Impact factor: 3.738

7.  Systems analysis of iron metabolism: the network of iron pools and fluxes.

Authors:  Tiago J S Lopes; Tatyana Luganskaja; Maja Vujić Spasić; Matthias W Hentze; Martina U Muckenthaler; Klaus Schümann; Jens G Reich
Journal:  BMC Syst Biol       Date:  2010-08-13

8.  THE UTILIZATION OF IRON AND THE RAPIDITY OF HEMOGLOBIN FORMATION IN ANEMIA DUE TO BLOOD LOSS.

Authors:  P F Hahn; J F Ross; W F Bale; G H Whipple
Journal:  J Exp Med       Date:  1940-05-31       Impact factor: 14.307

9.  RADIOACTIVE IRON ABSORPTION IN CLINICAL CONDITIONS: NORMAL, PREGNANCY, ANEMIA, AND HEMOCHROMATOSIS.

Authors:  W M Balfour; P F Hahn; W F Bale; W T Pommerenke; G H Whipple
Journal:  J Exp Med       Date:  1942-07-01       Impact factor: 14.307

10.  Effect of ethionine-induced pancreatic damage on iron absorption.

Authors:  T D KINNEY; N KAUFMAN; J KLAVINS
Journal:  J Exp Med       Date:  1955-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.